- Home
- PCYO vs CDXS Comparison
PCYO vs CDXS Comparison
Compare PCYO & CDXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCYO
- CDXS
- Stock Information
- Founded
- PCYO 1976
- CDXS 2002
- Country
- PCYO United States
- CDXS United States
- Employees
- PCYO N/A
- CDXS N/A
- Industry
- PCYO Water Supply
- CDXS Major Chemicals
- Sector
- PCYO Utilities
- CDXS Industrials
- Exchange
- PCYO Nasdaq
- CDXS Nasdaq
- Market Cap
- PCYO 267.7M
- CDXS 216.6M
- IPO Year
- PCYO N/A
- CDXS 2010
- Fundamental
- Price
- PCYO $11.10
- CDXS $2.64
- Analyst Decision
- PCYO
- CDXS Buy
- Analyst Count
- PCYO 0
- CDXS 2
- Target Price
- PCYO N/A
- CDXS $11.00
- AVG Volume (30 Days)
- PCYO 40.0K
- CDXS 538.3K
- Earning Date
- PCYO 11-12-2025
- CDXS 10-30-2025
- Dividend Yield
- PCYO N/A
- CDXS N/A
- EPS Growth
- PCYO 123.89
- CDXS N/A
- EPS
- PCYO 0.56
- CDXS N/A
- Revenue
- PCYO $27,447,000.00
- CDXS $57,164,000.00
- Revenue This Year
- PCYO N/A
- CDXS $12.88
- Revenue Next Year
- PCYO N/A
- CDXS $21.64
- P/E Ratio
- PCYO $19.84
- CDXS N/A
- Revenue Growth
- PCYO 40.36
- CDXS N/A
- 52 Week Low
- PCYO $9.65
- CDXS $1.90
- 52 Week High
- PCYO $14.63
- CDXS $6.08
- Technical
- Relative Strength Index (RSI)
- PCYO 54.73
- CDXS 52.60
- Support Level
- PCYO $11.03
- CDXS $2.51
- Resistance Level
- PCYO $11.33
- CDXS $2.73
- Average True Range (ATR)
- PCYO 0.26
- CDXS 0.11
- MACD
- PCYO -0.04
- CDXS 0.03
- Stochastic Oscillator
- PCYO 24.05
- CDXS 56.80
About PCYO Pure Cycle Corporation
Pure Cycle Corp is a diversified land and water resource development company. The company designs, constructs, manages, operates, and maintains water and wastewater systems. The firm operates in two business segments namely Water and wastewater resource development and Land development. It generates maximum revenue from the Land development segment. The land resource development segment includes all the activities necessary to develop and sell finished lots.
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.